Non-small cell lung cancer: radiation therapy for locoregional recurrence after complete resection
Authors:
- 1 December 2005
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 10 (6) , 425-428
Abstract
We investigated patterns of failure after radical radiation therapy in relation to the radiation field in patients with postsurgical locoregional recurrence of non-small cell lung cancer. Between 1992 and 2002, 31 patients with locoregional recurrence were treated with radiation therapy. At the time of radiation therapy, the sites of recurrence were the bronchial stump, the regional lymph nodes, the chest wall, and both the regional lymph nodes and the chest wall in 7, 20, 3, and 1 patient, respectively. The prescribed dose was 60 Gy in 30 fractions over 6 weeks in all patients. The response rate was 87%. The overall 1-year, 2-year, and 4-year Kaplan-Meier survival rates were 61%, 30%, and 15%, respectively, and the median survival time was 14 months. Locoregional relapse with or without distant metastasis occurred in 15 patients (in-field, 7; marginal, 7; out-field, 1), and distant metastasis alone occurred in 7 patients. The sites of marginal relapse were the upper margin in two patients, the ipsilateral margin in one patient, the contralateral margin in one patient, and the lower margin in three patients, respectively (in one patient, the data for marginal relapse overlapped). In all patients with relapse on the lower margin, the mediastinal lymph nodes were dissected at the initial surgery. Postoperative recurrent non-small cell lung cancer showed distinctive features: the response rate was high, and the incidence of marginal relapse was also high, as in small cell lung cancer. The incidence of lower marginal relapse was high, in contrast to that in surgery-naive patients.Keywords
This publication has 14 references indexed in Scilit:
- Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinomaCancer, 2004
- A single institutional subset analysis of the WJLCG study comparing concurrent and sequential chemoradiotherapy for stage III non-small-cell lung cancer.2004
- Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer.2003
- The impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancerRadiotherapy and Oncology, 2000
- Limited-stage small cell lung cancer: local failure after chemotherapy and radiation therapy.Radiology, 1998
- Radiation Therapy for Intrathoracic Recurrence of Non-Small Cell Lung CancerAmerican Journal of Clinical Oncology, 1997
- Chemotherapy plus Radiotherapy Compared with Radiotherapy Alone in the Treatment of Locally Advanced, Unresectable, Non-Small-Cell Lung CancerAnnals of Internal Medicine, 1996
- Strategy for lymphadenectomy in lung cancer three centimeters or less in diameterThe Annals of Thoracic Surgery, 1990
- Cancer recurrence after resection: T1 N0 non-small cell lung cancerThe Annals of Thoracic Surgery, 1990
- Site of Recurrence in Patients with Stages I and II Carcinoma of the Lung Resected for CureThe Annals of Thoracic Surgery, 1981